Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2000
11/22/2000EP1008098A4 Method for remote sensing analysis by decorrelation statistical analysis and hardware therefor
11/22/2000EP0871885A4 Attachment enhanced 293 cells
11/22/2000EP0868665A4 Fecal test method and device
11/22/2000EP0834072B1 Breath testing apparatus
11/22/2000EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
11/22/2000EP0765476B1 The use of sialic acid determination for determining alcohol consumption
11/22/2000CN2407361Y Multi-linkage urinary test paper
11/22/2000CN2407355Y Optical fiber biological sensor
11/22/2000CN1274424A Method for assaying hepatitis C virus
11/22/2000CN1274423A Testing device for determining analytes in liquid dairy product
11/22/2000CN1274422A Appts. and method for analyte detection
11/22/2000CN1274416A Method and system for determination of ternary refrigerant mixture
11/22/2000CN1274284A Methods of modulating serine/threnoine protein kinase function with 5-azaquinoxaline-based compounds
11/22/2000CN1274085A Protein chip, its preparing process and its application in screening monoclonal antibody
11/21/2000US6151519 Planar electrode
11/21/2000US6151405 System and method for cellular specimen grading
11/21/2000US6151379 Method and device for measuring density
11/21/2000US6151110 Measuring device for determining the concentration of a substance in a liquid
11/21/2000US6151108 On-line measurement of contaminant level in lubricating oil
11/21/2000US6150516 Solid phase supports, each having spatially discrete regions, each region having uniform population of identical tag complements selected from single mimimally cross-hybridizing set of oligonucleotides; large scale sequencing and analysis
11/21/2000US6150398 By administering to a human a synergistic combination of paclitaxel and a dna crosslinking antineoplastic agent, such as cisplatin
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150181 Mixing dimercaptosuccinic acid with ferrofluid-forming magnetic particles to produce particles with disulfide bonds, then reducing bonds at basic ph to form particles having reduced thiol groups; analysis of erythrocytes
11/21/2000US6150180 High throughput screening assay systems in microscale fluidic devices
11/21/2000US6150179 Measuring internuclear dipole-dipole interaction strengths between selected nuclei in sample of binder compound using nuclear magnetic resonance; accurate drug design and drug screening
11/21/2000US6150178 For accurate, one-step analysis without contaminating the sample; includes a membrane carrying the test chemistry and an elongated foam member for collecting specimen and which is drawn across the membrane to deliver the sample
11/21/2000US6150177 Device and process for determining the temperature of the gas sample flow during breath alcohol measurements
11/21/2000US6150176 Fluorescent protein sensors for measuring the pH of a biological sample
11/21/2000US6150175 Copper contamination control of in-line probe instruments
11/21/2000US6150174 Method for measurement of whole blood coagulation parameters
11/21/2000US6150172 Solvent extraction of isotonic or hypotonic aqueous preparation of biological material and increasing lyotropic activity of mixture to separate solvent from preparation to produce solvent containing abnormal prion protein; diagnosis
11/21/2000US6150161 Methods for the diagnosis of glaucoma
11/21/2000US6150158 Automatically depositing one seed into a small target container by controlling air pressure in a vertical hollow transport tube, detecting whether only one seed has been positioned, recording which containers are defective
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150147 Laying out a pattern of nucleotide sequences on surface of a substrate; forming layout of nucleic acid sequences on the surface of a substrate and reducing electrostatic charge during process
11/21/2000US6150137 Immunosuppressant target proteins
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150131 Screening for viricides that suppress interactions between cysteine and palmitic acid; mix cells infected with influenza virus, palmitic acid and modulator, monitor reduction in palmitic acid incorporation
11/21/2000US6150128 Reagents with enhanced performance in clinical diagnostic systems
11/21/2000US6150126 Daphnia reproductive bioassay for testing toxicity of aqueous samples and presence of an endocrine disrupter
11/21/2000US6150123 Affinity biotinylation
11/21/2000US6150122 Spheres coated with different human leukocyte antigens; for the accurate classification of human leukocyte antigens
11/21/2000US6150121 Monitoring immune response to grafted organ; incubating cytokines, tissue and lymphocytes, monitor lymphocyte activation, incubate tissue with reduced amount of cytokine and monitor lymphocyte activation, evaluate immune response
11/21/2000US6150120 Detecting preferential blood disorders; incubating platelets or megakaryocytes with stimulant, detect phosphorylation of tyrosine residues, the absence of phosphorylation is indicatve of blood disorder
11/21/2000US6150119 Serially transferring testing plugs in fluid channel; insertion of first test plug into channel, allow migration to sample detection device, insert second test plug and allow migration, duplicate for subsequent test plugs
11/21/2000US6150118 Detection of cartilage diseases with MIA
11/21/2000US6150117 Detecting cell proliferative defects; detecting thymosin or nucleotide sequences coding thymosin in sample, comparing thymosin content in sample and reference tissue, amplified thymosin in sample is indicator of cell proliferation defect
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150115 Monitoring compound content in a biocompatible fluid; mixing sample with immobilized antibody, labeling antigen-antibody complex, removing nonlabeled residues, detecting label and calculating compound content
11/21/2000US6150114 Method and reagent for monitoring blood levels of antiplantelet compounds
11/21/2000US6150113 Detecting hepatitis virion antigen in a sample; mixing immobilized antigen with a sample forming a complex, incubating antibody with complex, detecting bound antibody/antigen complexes in solid phase
11/21/2000US6150106 Method for analyzing biological substances in a conductive liquid medium
11/21/2000US6150105 Generating variable length copies of a nucleic acid from sample, hybridizing to reference nucleic acids, and detecting presence or absence of variations at the 3'-terminal position
11/21/2000US6150103 Compound for the immbolization of a biopolymer in a layer on surface
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6150100 Method for the detection of microsatellite instability for tumor diagnostics
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150095 Method for analyzing a polynucleotide containing a variable sequence
11/21/2000US6150094 Use of an osmolyte for reducing or abolishing no-covalent interactions of biological molecules to inert surfaces
11/21/2000US6150092 Nucleotide sequences which suppress the activity of vascular endothelial growth factors; for diagnosis and treatment of solid tumors, arthritis, diabetes or cancers; anticarcinogenic, antitumor, antiarthritic agents
11/21/2000US6150090 Nuclear factors associated with transcriptional regulation
11/21/2000US6150089 Method and characterizing polymer molecules or the like
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000US6149956 Eggs are subjected to nuclear magnetic resonance (nmr) treatment for obtaining an nmr image, and eggs are selected on basis of differences between nmr images of fertilized and unfertilized eggs
11/21/2000US6149915 Administering a herb salviae miltiorrhizae radix
11/21/2000US6149910 Peptides for the detection of HIV-1 group O
11/21/2000US6149891 Intravenous injectable mixture comprising radiology contrast agent and a cytoprotective agent which induces cells to generate nitric oxide to protect against damage by contrast agent; side effect reduction
11/21/2000US6149865 Strip comprising a porous absorbent carrier matrix impregnated with a test reagent comprising a ph chromogenic indicator selected from dibromothylsulfonphalein, thymolsulfonphthalein and 2-(phthalimidoethyl)phsophonic acid reagent
11/21/2000US6149819 Removing volatile halogenated compounds such as chloramines from the air and treating water in an indoor aquatic facility by monitoring the water's oxidation-reduction potential(orp); adding halogen donor and peroxide to maintain optimal orp
11/21/2000US6149636 Disposable article having proactive sensors
11/21/2000US6149606 Method and device for use in the diagnosis of inflammatory states in the urogenital tract
11/21/2000US6149588 Blood sugar value measuring method and apparatus
11/21/2000US6148659 Gas concentration monitor having a bridge configured flow system
11/21/2000CA2170592C Method for activation of polyanionic fluorescent dyes in low dielectric media with quaternary onium compounds
11/21/2000CA2028094C Carbohydrateacryl- and methacrylcopolymers and their manufacture
11/21/2000CA2014119C Methods and devices for the separation of plasma or serum from whole blood, collection of plasma or serum, and reagent delivery system
11/16/2000WO2000068695A2 Reagent and process for peptide/protein differentiation using circular dichroism detection
11/16/2000WO2000068694A1 Method for diagnosis of alzheimer's disease
11/16/2000WO2000068693A2 METHODS BASED ON LOCALIZATION OF Hsp90 TO THE CENTROSOME
11/16/2000WO2000068692A1 A method of detecting an analyte using semiconductor nanocrystals
11/16/2000WO2000068691A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities
11/16/2000WO2000068690A1 Method for detecting proteins under mutual interaction
11/16/2000WO2000068689A1 Cell separation device and methods for use
11/16/2000WO2000068688A1 Polysaccharide structure and sequence determination
11/16/2000WO2000068687A2 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000WO2000068686A1 High-throughput screening assays for modulators of mitochondrial membrane potential
11/16/2000WO2000068685A1 Composition and method for measuring the foliar uptake of agrochemicals
11/16/2000WO2000068684A1 Method for anticipating, delaying and/or preventing the risk of spontaneous combustion and/or explosion of an explosive atmosphere
11/16/2000WO2000068683A1 Method and apparatus for determining the type and/or condition of disease and method and apparatus for screening drug
11/16/2000WO2000068682A2 Device for investigating materials
11/16/2000WO2000068675A1 Use of spatiotemporal response behavior in sensor arrays to detect analytes in fluids
11/16/2000WO2000068674A1 Mouth odor detection device and regulating method therefor
11/16/2000WO2000068669A1 Polarization label for measuring 3-dimensional orientation
11/16/2000WO2000068668A1 Method and device for fluorescence measurement
11/16/2000WO2000068661A2 Detection of cellular exposure to addictive drugs
11/16/2000WO2000068434A2 Multiple tag analysis
11/16/2000WO2000068430A1 Rnase p polypeptides, polynucleotides, and methods using their mechanisms of action
11/16/2000WO2000068421A2 Method for detecting microorganisms in a sample
11/16/2000WO2000068420A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
1 ... 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 ... 3937